Zimmer Biomet 

€94
145
-€1.82-1.9% Friday 06:02

统计数据

当日最高
94
当日最低
94
52周最高
-
52周最低
-
成交量
0
平均成交量
-
市值
19.72B
市盈率
22.41
股息收益率
0.93%
股息
0.87

即将到来

股息

0.93%股息收益率
10年增长
0.87%
5年增长
N/A
3年增长
N/A
1年增长
N/A

收益

31Oct预期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一个
1.6
1.8
2
2.2
预期每股收益
1.801116
实际每股收益
N/A

人们还关注

此列表基于关注ZIM.F的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Show more...
首席执行官
Mr. Ivan Tornos
员工
18000
国家
US
ISIN
US98956P1021
WKN
000753718

上市公司